(Q37904901)

25 August 2017

1 reference

title

Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review (English)

1 reference

25 August 2017

1 reference

1 reference

1 reference

1 reference

Kuniya Tanaka

1

1 reference

25 August 2017

Yasushi Ichikawa

series ordinal

2

1 reference

25 August 2017

Itaru Endo

series ordinal

3

1 reference

25 August 2017

publication date

26 July 2011

1 reference

International Journal of Clinical Oncology

25 August 2017

published in

1 reference

25 August 2017

volume

16

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

452-463

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-011-0291-6

25 August 2017

exact match

0 references

cites work

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Management strategies for colorectal liver metastases--Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Determinants of survival in liver resection for colorectal secondaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Impact of steatosis on perioperative outcome following hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Hepatic steatosis as a potential risk factor for major hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Perioperative chemotherapy for resectable hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Preoperative portal vein embolization with a new liquid embolic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Promotion of hepatic metastases by liver resection in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Liver regeneration stimulates tumor metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Aggressive liver resection including major-vessel resection for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Caval invasion by liver tumor is limited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Cancer chronotherapy: principles, applications, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Prospective Evaluation of Two-Stage Hepatectomy Combined with Selective Portal Vein Embolisation and Systemic Chemotherapy for Patients with Unresectable Bilobar Colorectal Liver Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Profile of Plasma Angiogenic Factors Before and After Hepatectomy for Colorectal Cancer Liver Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0291-6

Clinical studies of new material for portal vein embolization: comparison of embolic effect with different agents

21 January 2018

1 reference

12 December 2020

Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.

1 reference

12 December 2020

Role of hepatectomy in treating multiple bilobar colorectal cancer metastases

1 reference

12 December 2020

CASH (Chemotherapy-Associated Steatohepatitis) costs

1 reference

12 December 2020

Preoperative Portal Vein Embolization for Extended Hepatectomy

1 reference

12 December 2020

Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection

1 reference

12 December 2020

Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats

1 reference

12 December 2020

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

12 December 2020

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors

1 reference

12 December 2020

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases

1 reference

12 December 2020

Portal vein embolization before right hepatectomy: prospective clinical trial

1 reference

12 December 2020

Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases

1 reference

12 December 2020

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

1 reference

12 December 2020

Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer--too good to be true?

1 reference

12 December 2020

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

1 reference

12 December 2020

Pattern of recurrence in liver resection for colorectal secondaries

1 reference

12 December 2020

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

12 December 2020

Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome

1 reference

12 December 2020

R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy

1 reference

12 December 2020

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection

1 reference

12 December 2020

Interval debulking surgery for advanced epithelial ovarian cancer

1 reference

12 December 2020

Surgery vs surgery and chemotherapy for colorectal liver metastases

1 reference

12 December 2020

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy

1 reference

12 December 2020

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

1 reference

12 December 2020

Aggressive surgical resection for hepatic metastases involving the inferior vena cava

1 reference

12 December 2020

Extent of pathologic invasion of the inferior vena cava in resected liver cancer compared with possible caval invasion diagnosed by preoperative images

1 reference

12 December 2020

Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy

1 reference

12 December 2020

Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases

1 reference

12 December 2020

A retrospective study of the natural history of patients with liver metastases from colorectal cancer

1 reference

12 December 2020

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

1 reference

12 December 2020

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

12 December 2020

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

12 December 2020

10.1007/S10147-011-0291-6

Identifiers

DOI

1 reference

25 August 2017

1 reference